Immune response and immunopathology during toxoplasmosis - Test2 - elhamkhani - TriplyDB

Immune response and immunopathology during toxoplasmosis

Immune response and immunopathology during toxoplasmosis

http://www.wikidata.org/entity/Q24612341

about

Recombinant Toxoplasma gondii phosphoglycerate mutase 2 confers protective immunity against toxoplasmosis in BALB/c mice Recent advances in understanding apicomplexan parasites Toxoplasma gondii-induced neuronal alterations Fundamental Roles of the Golgi-Associated Toxoplasma Aspartyl Protease, ASP5, at the Host-Parasite Interface Pro-inflammatory immune responses are associated with clinical signs and symptoms of human anaplasmosis.Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice.Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.Astrocytic TGF-β signaling limits inflammation and reduces neuronal damage during central nervous system Toxoplasma infection.Profiling of the perturbed metabolomic state of mouse spleen during acute and chronic toxoplasmosis.DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice Biomarker analysis revealed distinct profiles of innate and adaptive immunity in infants with ocular lesions of congenital toxoplasmosis Immune profiling of pregnant Toxoplasma-infected US and Colombia patients reveals surprising impacts of infection on peripheral blood cytokines Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infection A ThPOK-LRF transcriptional node maintains the integrity and effector potential of post-thymic CD4+ T cells.Evaluation of immuno-efficacy of a novel DNA vaccine encoding Toxoplasma gondii rhoptry protein 38 (TgROP38) against chronic toxoplasmosis in a murine model CXCR3-dependent CD4⁺ T cells are required to activate inflammatory monocytes for defense against intestinal infection.Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii.Border maneuvers: deployment of mucosal immune defenses against Toxoplasma gondii.Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii.Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice.Nonreplicating, cyst-defective type II Toxoplasma gondii vaccine strains stimulate protective immunity against acute and chronic infection Generation and Identification of Peptide-Based Monoclonal Antibodies Against Vacuolar Proton Pyrophosphatase of Toxoplasma gondii.Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected Patients.Toxoplasma-SPECIFIC IgG SUBCLASS ANTIBODY RESPONSE IN CEREBROSPINAL FLUID SAMPLES FROM PATIENTS WITH CEREBRAL TOXOPLASMOSIS Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: a hospital-based study.Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.Serological study of Toxoplasma gondii infection in Turkoman horses in the North Khorasan Province, Iran.Targeting tumors with nonreplicating Toxoplasma gondii uracil auxotroph vaccines.Characterization of aspartyl aminopeptidase from Toxoplasma gondii.Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of Toxoplasmosis.Lectins from Synadenium carinatum (ScLL) and Artocarpus heterophyllus (ArtinM) Are Able to Induce Beneficial Immunomodulatory Effects in a Murine Model for Treatment of Toxoplasma gondii Infection.Toxoplasma gondii serostatus is not associated with impaired long-term survival after heart transplantation.Protozoan Parasites and Type I IFNs.Toxoplasma gondii Elongation Factor 1-Alpha (TgEF-1α) Is a Novel Vaccine Candidate Antigen against Toxoplasmosis.Shear forces enhance Toxoplasma gondii tachyzoite motility on vascular endothelium.CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites.Homeostatic control of regulatory T cell diversity.

P2860

Q23071101-27BCF175-5844-490E-B483-51AA87480522 Q26747055-CBDAFA32-9C00-4F65-871D-5DAD6FC26B5B Q27027025-42BE87EA-08F8-4E0A-A1AA-A179BB2705BA Q27316912-6A0B2F02-A1C9-42BB-881B-8308B14A8E2C Q33442815-BA61CD02-D1A7-41EC-A036-57FB7F5550A8 Q33610342-9B658B10-A854-406D-90EA-60714B4DD556 Q33776827-83158675-2715-420E-A496-AF1C2CE7417C Q33822879-0365784A-3E9D-4706-BAA7-4959EE51144A Q33916911-D8903039-A055-473B-B7A5-6AD3AF5D80D2 Q34184744-18367758-1CB9-47EB-A4C3-2735FBDEA4C7 Q34196487-7E395805-9571-4FA8-B356-3A0CAC491E26 Q34307139-E0962C77-119A-45FC-92CE-3E1E58C50BAF Q34315648-65CE43A3-4088-4277-A680-EBD1E1680DD4 Q34435073-5A54BDD1-938C-411C-A7F4-CFC206D0D5BA Q34611694-E8B65B94-8605-445F-88C2-58C9B128E8CA Q34667736-A7A90F27-FFBF-48AF-8EB2-C24CEB29A846 Q35018100-470F52AA-401E-4D68-A6B6-93FF2E9C74FA Q35033334-75C6F0D6-E378-46FB-9CDD-AA9A3837E32C Q35143581-266E1DCA-BFCA-4773-8849-A65517A38C3F Q35145091-C778DDED-5C0F-49B3-8D62-935027CD1BB0 Q35425382-C0B2696A-B437-4F34-B306-C39B3D55591C Q35439431-FE4FFE79-A885-4B31-B1CE-F3D3917B44D6 Q35822193-565C77F3-945D-4A98-8DDB-ECB535710695 Q35843444-8D84B84F-5CA0-455C-9610-CC9BCFC5D2F9 Q35889712-A0A6FCC1-FF27-4691-A7E6-1E35D38A843A Q36321022-2964D9BB-7266-4574-871E-38EA1D969482 Q36361649-E6430B21-5D97-47B7-B95E-1BA3BF4CC844 Q36541588-D643A1F7-8D9E-40EA-B5AA-85AAB06A1B6B Q36691483-422DD8CE-5575-4F8C-AFD4-6C663A942780 Q37053255-4589FFF5-EE03-4E79-A9DE-18C9DCF213FD Q37184436-9E7852F5-572E-40E8-AB49-E9E836F657C4 Q37291149-FB080305-1522-4371-B7E1-8B3E92E9D324 Q37401607-5E985D76-D984-424A-BFB9-C878F9C5C691 Q37438089-3C1B191C-D548-4F2C-BA22-7425A9DADEFB Q37464884-5F07BB5C-1C6B-4BF2-B09F-06327284EE52 Q37592659-32217AE7-DB87-4837-8E6A-AC83E6A2376E Q37638329-F1912513-34C9-4B2E-8F6E-B3B2F3ACBB74 Q37687837-96475D94-0452-46B5-B81E-230FBAA3C1EA Q37698282-84D74FFB-BCA3-467A-BAFA-C674E947E845 Q38183674-25E974DE-2E54-4DAA-ADB8-A5A18C7887A0

P2860

Immune response and immunopathology during toxoplasmosis

http://www.wikidata.org/entity/Q24612341

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Immune response and immunopathology during toxoplasmosis

@ast

Immune response and immunopathology during toxoplasmosis

@en

Immune response and immunopathology during toxoplasmosis

@nl

type

label

Immune response and immunopathology during toxoplasmosis

@ast

Immune response and immunopathology during toxoplasmosis

@en

Immune response and immunopathology during toxoplasmosis

@nl

prefLabel

Immune response and immunopathology during toxoplasmosis

@ast

Immune response and immunopathology during toxoplasmosis

@en

Immune response and immunopathology during toxoplasmosis

@nl

P1433

Q24612341-1E812B5F-CADE-4FC1-80B6-FF4F0FB6B684

P1476

Q24612341-78D7AA8F-284F-4D01-A33F-F43DA75A8E31

P2093

Q24612341-357C8572-473A-4EA7-A82E-45BC907CF5F8

Q24612341-5E2D2376-46C6-4033-9B07-103EADEA8613

Q24612341-EF6FDFA5-6900-46C6-B086-B4A652FB2FC2

P2860

Q24612341-013FF021-FDAB-4CD5-A67B-487E6012F182

Q24612341-0271CCDE-107D-4A12-B287-7EAD0E242D52

Q24612341-03508021-AE54-4E77-A892-A24F6A20F0FF

Q24612341-0377DE4A-88EC-453E-8645-A9AB322A8E69

Q24612341-040DFBEE-D7DA-42E8-A7FE-7740BBAEA04D

Q24612341-04BD764E-7513-4F26-BF9D-377002437636

Q24612341-0648CBF3-81C0-4FE7-A300-16C36470BE58

Q24612341-0876D8B4-DBAD-4435-8270-379EE7F4C596

Q24612341-09985A46-3D1B-4874-A816-2031AF3F58A9

Q24612341-09DED34A-FC45-4822-89FE-F2FE323B722E

P2888

Q24612341-599722C1-2289-4255-8144-85CBD7AA6702

P304

Q24612341-02B16BFC-BEC7-4C60-8B36-77D9350AD8DE

P31

Q24612341-51993A43-9731-4368-84FF-0A25D3D6EF35

P3181

Q24612341-22AEBA2C-E979-4BF1-A6B6-6DA64C5C1197

P356

Q24612341-ECEB9793-EDB5-48B9-BF9C-94CA1DCEA5D2

P407

Q24612341-55F44603-9DF1-4899-B4CD-477AD413B086

P433

Q24612341-399D8C07-AC65-4A03-AC3C-852EFAD8637A

P478

Q24612341-43A8300F-A330-4246-A2D1-E7A788C3C2E1

P577

Q24612341-A892A155-D4A6-429B-B06A-F24E75521EA7

P6179

Q24612341-8AAC60EA-8929-4986-BA21-734A29E04658

P698

Q24612341-E1D90B5E-AB6E-4B30-A75B-A8F60F75BA95

P921

Q24612341-8DC7D75E-7537-4FCC-AA7E-9FFE116098A3

P932

Q24612341-99FF4309-2884-428D-9CEF-52145CA20F1B

P3181

P356

S00281-012-0339-3

P1433

Seminars in Immunopathology

P1476

Immune response and immunopathology during toxoplasmosis

@en

P2093

Christopher A Hunter

http://www.w3.org/2001/XMLSchema#string

Christopher D Dupont

http://www.w3.org/2001/XMLSchema#string

David A Christian

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of the Toxoplasma gondii parasitophorous vacuole by IFNgamma-inducible immunity-related GTPases (IRG proteins) triggers necrotic cell death

Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.

Antigen presentation and T cell stimulation by dendritic cells

Interleukin-10 and the interleukin-10 receptor

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

Coordinated loading of IRG resistance GTPases on to the Toxoplasma gondii parasitophorous vacuole

Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence

The activation mechanism of Irga6, an interferon-inducible GTPase contributing to mouse resistance against Toxoplasma gondii

In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas

Toxoplasmosis: A history of clinical observations

P2888

s00281-012-0339-3

P304

793-813

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

796106

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00281-012-0339-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1020129694

http://www.w3.org/2001/XMLSchema#string

P698

22955326

http://www.w3.org/2001/XMLSchema#string

P921

P932

3498595

http://www.w3.org/2001/XMLSchema#string